63 related articles for article (PubMed ID: 12553555)
1. Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor.
Ruggeri RM; Villari D; Simone A; Scarfi R; Attard M; Orlandi F; Barresi G; Trimarchi F; Trovato M; Benvenga S
J Endocrinol Invest; 2002 Dec; 25(11):959-66. PubMed ID: 12553555
[TBL] [Abstract][Full Text] [Related]
2. Prevention of carrageenan-induced pleurisy in mice by anti-CD30 ligand monoclonal antibody.
Di Paola R; Di Marco R; Mazzon E; Genovese T; Bendtzen K; Macrì B; Nicoletti F; Cuzzocrea S
Clin Immunol; 2004 Oct; 113(1):64-73. PubMed ID: 15380531
[TBL] [Abstract][Full Text] [Related]
3. EXPRESSION OF MENIN IN THE HUMAN THYROID GLAND.
Capraru OM; Decaussin-Petrucci M; Joly MO; Borda A; Fanfaret IS; Borson-Chazot F; Selmi-Ruby S
Acta Endocrinol (Buchar); 2017; 13(2):154-160. PubMed ID: 31149167
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of interleukin 6 in undifferentiated thyroid carcinoma: in vitro and in vivo studies.
Basolo F; Fiore L; Pollina L; Fontanini G; Conaldi PG; Toniolo A
Clin Cancer Res; 1998 Feb; 4(2):381-7. PubMed ID: 9516926
[TBL] [Abstract][Full Text] [Related]
5. Systematic pharmacology-based strategy to explore the mechanism of Semen Strychni for treatment of papillary thyroid carcinoma.
Mao J; Tang L; Fang L; Tian C; Zhu Z; Li Y
Sci Rep; 2023 Oct; 13(1):18492. PubMed ID: 37898675
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective Effect of miR-483-5p Against Cardiac Arrest-Induced Mitochondrial Dysfunction Mediated Through the TNFSF8/AMPK/JNK Signaling Pathway.
Zhang Q; Zhan H; Liu C; Zhang C; Wei H; Li B; Zhou D; Lu Y; Huang S; Cheng J; Li S; Wang C; Hu C; Liao X
Cell Mol Neurobiol; 2023 Jul; 43(5):2179-2202. PubMed ID: 36266523
[TBL] [Abstract][Full Text] [Related]
7. Interleukin‑6 signalling as a valuable cornerstone for molecular medicine (Review).
Trovato M; Sciacchitano S; Facciolà A; Valenti A; Visalli G; Di Pietro A
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33907833
[TBL] [Abstract][Full Text] [Related]
8. Interleukins in Thyroid Cancer: From Basic Researches to Applications in Clinical Practice.
Xi C; Zhang GQ; Sun ZK; Song HJ; Shen CT; Chen XY; Sun JW; Qiu ZL; Luo QY
Front Immunol; 2020; 11():1124. PubMed ID: 32655554
[TBL] [Abstract][Full Text] [Related]
9. P2X7 in Cancer: From Molecular Mechanisms to Therapeutics.
Lara R; Adinolfi E; Harwood CA; Philpott M; Barden JA; Di Virgilio F; McNulty S
Front Pharmacol; 2020; 11():793. PubMed ID: 32581786
[TBL] [Abstract][Full Text] [Related]
10. Effect of IL-6 on proliferation of human thyroid anaplastic cancer stem cells.
Zheng R; Chen G; Li X; Wei X; Liu C; Derwahl M
Int J Clin Exp Pathol; 2019; 12(11):3992-4001. PubMed ID: 31933795
[TBL] [Abstract][Full Text] [Related]
11. Significance of Interleukin-6 in Papillary Thyroid Carcinoma.
Kobawala TP; Trivedi TI; Gajjar KK; Patel DH; Patel GH; Ghosh NR
J Thyroid Res; 2016; 2016():6178921. PubMed ID: 27034885
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathways associated with aggressiveness of papillary thyroid cancer.
Benvenga S; Koch CA
Curr Genomics; 2014 Jun; 15(3):162-70. PubMed ID: 24955023
[TBL] [Abstract][Full Text] [Related]
13. Interleukins as markers of inflammation in malignant and benign thyroid disease.
Provatopoulou X; Georgiadou D; Sergentanis TN; Kalogera E; Spyridakis J; Gounaris A; Zografos GN
Inflamm Res; 2014 Aug; 63(8):667-74. PubMed ID: 24794392
[TBL] [Abstract][Full Text] [Related]
14. Association of XIAP and P2X7 receptor expression with lymph node metastasis in papillary thyroid carcinoma.
Gu LQ; Li FY; Zhao L; Liu Y; Chu Q; Zang XX; Liu JM; Ning G; Zhao YJ
Endocrine; 2010 Oct; 38(2):276-82. PubMed ID: 20972735
[TBL] [Abstract][Full Text] [Related]
15. The tyrosine kinase receptor c-met, its cognate ligand HGF and the tyrosine kinase receptor trasducers STAT3, PI3K and RHO in thyroid nodules associated with Hashimoto's thyroiditis: an immunohistochemical characterization.
Ruggeri RM; Vitarelli E; Barresi G; Trimarchi F; Benvenga S; Trovato M
Eur J Histochem; 2010 Jun; 54(2):e24. PubMed ID: 20558345
[TBL] [Abstract][Full Text] [Related]
16. The (-174) G/C polymorphism in the interleukin-6 gene is associated with risk of papillary thyroid carcinoma in Turkish patients.
Ozgen AG; Karadeniz M; Erdogan M; Berdeli A; Saygili F; Yilmaz C
J Endocrinol Invest; 2009 Jun; 32(6):491-4. PubMed ID: 19494710
[TBL] [Abstract][Full Text] [Related]
17. Serum hepatocyte growth factor is increased in Hashimoto's thyroiditis whether or not it is associated with nodular goiter as compared with healthy non-goitrous individuals.
Ruggeri RM; Sciacchitano S; Vitale A; Cardelli P; Galletti M; Vitarelli E; Barresi G; Benvenga S; Trimarchi F; Trovato M
J Endocrinol Invest; 2009 May; 32(5):465-9. PubMed ID: 19468262
[TBL] [Abstract][Full Text] [Related]
18. Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases.
Linkov F; Ferris RL; Yurkovetsky Z; Marrangoni A; Velikokhatnaya L; Gooding W; Nolan B; Winans M; Siegel ER; Lokshin A; Stack BC
Proteomics Clin Appl; 2008 Oct; 2(12):1575-1585. PubMed ID: 19234619
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
